Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Senate Finance Dives Deeper Into PBM Weeds, Including Brand Over Generic Preferences
Jul 19 2023
•
By
Sarah Karlin-Smith
The Senate Finance Committee wants PBM justification of brand vs. generic, biosimilar tiering preferences • Source: Shutterstock
More from Policy & Regulation
More from Generics Bulletin